This case further supports
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
β Scribed by Denise Walsh-McMonagle; David Green
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 83 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND. Thrombophlebitis migrans is a major cause of morbidity in approxi-
David Green, M.D.,
π SIMILAR VOLUMES
Objective: To evaluate changes in bone density in women receiving enoxaparin sodium during pregnancy. Methods: Bone density in the proximal femur was serially measured in 16 women receiving enoxaparin sodium (40 mg daily) during pregnancy. Baseline measurements were taken within 2 weeks of starting
Local drug delivery can be achieved with active injection systems or passive contact of a compound with the arterial wall. The Dispatcht catheter allows for passive diffusion of drugs from drug compartments while preserving blood flow through the central conduit. The aim of this study was to investi
## Abstract ## Objective To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus lowβdose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL). ## Method
## Abstract The biphasic hydrogenations of a number of polymeric materials, polybutadiene (PBD), nitrileβbutadiene rubber (NBR) and styreneβbutadiene rubber (SBR), were investigated in a toluene/__N,Nβ²β__butylmethylimidazolium tetrafluoroborate, (BMI^+^BF~4~^β^) system with a waterβsoluble analogue